![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » NEW DRUGS WILL HELP DRIVE THE PRESCRIPTION PAIN TREATMENT MARKET TO $50 BILLION IN 2020
NEW DRUGS WILL HELP DRIVE THE PRESCRIPTION PAIN TREATMENT MARKET TO $50 BILLION IN 2020
May 30, 2006
Decision Resources, Inc., one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that new first-in-class treatments, including drugs from Vertex/GlaxoSmithKline, Rinat Neuroscience, Avigen, and Pharmos will expand the market to treat pain in the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan to nearly $50 billion in 2020.
PR Newswire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct